Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine versus quetiapine for agitated delirium in ICU
ACTRN12624001075572Phase 2Terminated
- Sponsor
- Austin Hospital
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in delirium comparing Guanfacine with Quetiapine (2 arms). Primary endpoint: Hours alive and agitation/coma-free. Started Dec 2024; status: terminated.
02
Drugs
guanfacinequetiapine
03
Conditions
delirium
Beyond the preview
Go deeper on ACTRN12624001075572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001075572.